Citation noticeOur citation system is being overhauled
References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.
ETH-CAT
ETH-CAT is an N-alkylated synthetic cathinone1 with empathogenic qualities. It is described as producing relatively mild stimulation and limited euphoria, giving it a more functional character. Its main effects are short-lived, although subtle stimulation reportedly persists afterward. The short active duration can encourage compulsive redosing. Adverse effects include insomnia, jaw tension, and teeth grinding. It has also reportedly been sold as ecstasy alongside mephedrone.
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
Although reports on ethylcathinone use are relatively scarce, available information indicates patterns consistent with other substituted cathinones. Compulsive redosing appears common, with users frequently combining routes of administration—for example, alternating between oral and insufflated doses within a single session. The urge to recapture initial effects often leads to subsequent doses that exceed the starting amount or are taken in rapid succession. Many experience reports describe difficulty resisting additional doses once effects begin to diminish, with some users unintentionally consuming a gram or more in a single session. Individual responses to any given dose can vary substantially, and what produces manageable effects in one person may be dangerous for another.
Duration
Subjective Effects
Pharmacology
Pharmacodynamics
ETH-CAT acts primarily as a norepinephrine releasing agent and is a selective substrate for the norepinephrine transporter (NET). It also inhibits dopamine reuptake2, although this activity is relatively weak.
Pharmacokinetics
ETH-CAT is expected to undergo N-dealkylation to a more active metabolite, but this metabolic pathway is proposed rather than established.
Interactions
An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.
Tolerance
Tolerance timelines are rules of thumb, not exact schedules, and vary widely between individuals and use patterns.
All dopaminergic stimulants
Harm Potential
Addiction & Dependence
Psychological
LowChronic ETH-CAT use is considered mildly addictive, with a low potential for abuse, although psychological dependence can develop in some users and insufflation is more associated with compulsive use. Many users report difficulty resisting redosing after a strong dose as effects subside, and reports of unexpectedly consuming a gram or more are common.
Physical
LowPhysical dependence appears unlikely, with withdrawal symptoms expected to be minimal and unlikely to be life-threatening.
Toxicity
The exact toxic dose of ETH-CAT is unknown.
History & Culture
Rothman and Baumann included ethcathinone alongside other psychostimulants in a 2006 paper on its pharmacology.…
Legality
International
Grey-area status is reported in many jurisdictions.
By Country
References
Citations
Further Reading
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass reviewPending
Not yet reviewed: this article is pending editorial review by Lyrea.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the ETH-CAT article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.